[6-K] Foresight Autonomous Holdings Ltd. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Foresight Autonomous Holdings Ltd. (FRSX) submitted a Form 6-K announcing that its Eye-Net solution is entering a large-scale live public transportation safety trial in France together with Renault Group and Orange. The update is provided through a press release dated November 20, 2025, which is furnished as Exhibit 99.1.

The first five paragraphs and the forward-looking statements section of this press release are incorporated by reference into Foresight’s existing shelf registration statements on Form F-3 and equity compensation registrations on Form S-8, making the trial information and related forward-looking disclosures part of those offerings.

Insights

Equity research analyst

Foresight highlights a French safety trial with Renault and Orange, but no financial details are disclosed.

Foresight Autonomous Holdings reports that its Eye-Net technology will participate in a large-scale live public transportation safety trial in France in collaboration with Renault Group and Orange. This positions the company alongside prominent automotive and telecom partners, indicating commercial and technical engagement in real-world mobility safety use cases.

The company also incorporates portions of the November 20, 2025 press release into its Form F-3 and Form S-8 registration statements, so the trial description and forward-looking statements now formally support existing securities offering frameworks. The filing, however, does not quantify contract size, revenue potential, or timing.

From an investment perspective, this looks like a potentially strategic validation step for Eye-Net rather than a clearly measurable financial event. Future updates in subsequent filings or press releases would need to specify commercial terms or deployment outcomes before the impact can be fully assessed.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of: November 2025 (Report No. 2)

Commission file number: 001-38094

FORESIGHT AUTONOMOUS HOLDINGS LTD.

(Translation of registrant’s name into English)

7 Golda Meir

Ness Ziona 7403650 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

CONTENTS

Attached hereto and incorporated herein is Foresight Autonomous Holdings Ltd.’s (the “Registrant”) press release issued on November 20, 2025, titled “Foresight: Eye-Net Together with Renault Group and Orange Enter Large-Scale Live Public Transportation Safety Trial in France.” A copy of the press release is furnished herewith as Exhibit 99.1.

The first five paragraphs and the section titled “Forward-Looking Statements” of press release are incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-276709 and 333-286221) and Form S-8 (Registration Nos. 333-229716, 333-239474, 333-268653 and 333-280778), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit No.		Description
99.1		Press release issued by Foresight Autonomous Holdings Ltd. on November 20, 2025, titled “Foresight: Eye-Net Together with Renault Group and Orange Enter Large-Scale Live Public Transportation Safety Trial in France.”

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Foresight Autonomous Holdings Ltd.
	(Registrant)
Date: November 20, 2025	By:	/s/ Eli Yoresh
	Name:	Eli Yoresh
	Title:	Chief Financial Officer

FAQ

What did Foresight Autonomous Holdings (FRSX) report in its latest Form 6-K?

Foresight Autonomous Holdings reported that its Eye-Net solution, together with Renault Group and Orange, is entering a large-scale live public transportation safety trial in France, as described in a November 20, 2025 press release furnished as Exhibit 99.1.

Which partners are involved in FRSX's public transportation safety trial in France?

The trial in France involves Foresight’s Eye-Net solution in collaboration with Renault Group and Orange, according to the press release referenced in the Form 6-K.

How does this Form 6-K affect Foresight Autonomous Holdings' existing registration statements?

The first five paragraphs and the Forward-Looking Statements section of the November 20, 2025 press release are incorporated by reference into Foresight’s Form F-3 registration statements (File Nos. 333-276709 and 333-286221) and its Form S-8 registration statements (Nos. 333-229716, 333-239474, 333-268653 and 333-280778).

Does the FRSX Form 6-K disclose any financial impact from the Renault and Orange trial?

The Form 6-K notes the large-scale live public transportation safety trial with Renault Group and Orange but does not provide specific financial metrics such as revenue, contract value, or profitability related to the trial.

What document contains the detailed information about FRSX’s safety trial in France?

Detailed information is contained in Foresight Autonomous Holdings’ press release dated November 20, 2025, titled “Foresight: Eye-Net Together with Renault Group and Orange Enter Large-Scale Live Public Transportation Safety Trial in France,” which is furnished as Exhibit 99.1 to the Form 6-K.

Who signed the Form 6-K for Foresight Autonomous Holdings Ltd.?

The Form 6-K was signed on behalf of Foresight Autonomous Holdings Ltd. by Eli Yoresh, who serves as the company’s Chief Financial Officer, dated November 20, 2025.